Explore more publications!

Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

Press releases published on December 15, 2025

Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
Ipsen finalise l'acquisition d'ImCheck Therapeutics, élargissant ainsi son portefeuille de produits oncologiques
Booking Health Releases 2026 Rankings of Germany’s Most Trusted Cancer Hospitals for International Patients
U.S. Court of Appeals Affirms Novarad’s ’807 Patent as Company Continues to Defend Leadership in Augmented Reality Surgical Navigation
New research in ONCOLOGY® identifies gaps between gynecologic cancer disease burden and clinical trial availability at UCLA Jonsson Comprehensive Cancer Center
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer
TRIMEDX launches TRIMEDX-AIQ™, an AI-native clinical asset intelligence offering built on the industry’s most extensive repository of medical device data
Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™
Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances
BetaGlue Therapeutics Receives Belgium Ministry of Health Approval for YntraDose Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
BetaGlue Therapeutics erhält Genehmigung des belgischen Gesundheitsministeriums für klinische Studie mit YntraDose bei inoperablem lokal fortgeschrittenem Bauchspeicheldrüsenkrebs (uLA-PDAC)
BetaGlue Therapeutics obtient l’autorisation du ministère de la Santé belge pour mener un essai clinique portant sur YntraDose dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)
NeOnc Technologies Reports Updated Clinical Results
SPR Reaches Milestone 50,000th Implant of the SPR® SPRINT® PNS System
Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma
Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease
ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
NetraMark Achieves Major FDA Milestone
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions